Results 31 to 40 of about 37,740 (162)

Mutation-independent treatment of autosomal dominant Retinitis Pigmentosa (adRP) [PDF]

open access: yes, 2010
Viral-mediated gene therapy holds great promise for the treatment of severe inherited retinal diseases, such as Retintitis Pigmentosa (RP), which is caused by mutations in genes preferentially expressed in photoreceptor cells. The availability of vectors
Mussolino, Claudio
core  

: Peropsin in retinitis pigmentosa [PDF]

open access: yes, 2007
Many genes from retinoid metabolism cause retinitis pigmentosa. Peropsin, an opsin-like protein with unknown function, is specifically expressed in apical retinal pigment epithelium microvilli.
Hamel, Christian, P.   +5 more
core   +1 more source

Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients

open access: yesStem Cell Research & Therapy, 2017
Background Retinitis pigmentosa is a common genetic disease that causes retinal degeneration and blindness for which there is currently no curable treatment available.
Yong Liu   +8 more
doaj   +1 more source

Towards identifying the ADRP gene in a large South African family with retinitis pigmentosa [PDF]

open access: yes, 2000
Bibliography: leaves 162-190.The present study was initiated with the aim of elucidating the molecular genetic basis of the RP phenotype segregating in a large SA family of British origin.
Goliath, René
core  

The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation [PDF]

open access: yes, 2002
Mutations in the photopigment rhodopsin are the major cause of autosomal dominant retinitis pigmentosa. The majority of mutations in rhodopsin lead to misfolding of the protein.
Munro, PMG   +3 more
core  

Retinitis Pigmentosa [PDF]

open access: yes, 1964
Retinitis pigmentosa is a chronic, progressive, hereditary disease of unknown aetiology. The symptoms of the disease follow a set pattern of progression and usually terminate with blindness. It starts the insidious path to blindness at various ages.
Hewett, Joe D.
core   +1 more source

Macular Hole of the Left Eye in a 41-year-old Patient with Retinitis pigmentosa. A Case Report

open access: yesOkulistyka
Retinitis pigmentosa is characterized by degeneration of the photoreceptors or retinal pigment epithelium and causes progressive vision loss. The disease can lead to night blindness, reduced field of vision and finally to complete loss of vision.
Bożena Kmak   +3 more
doaj   +1 more source

Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa.

open access: yesPLoS ONE, 2022
Cystoid macular edema (CME) is a major cause of central visual deterioration in retinitis pigmentosa. The exact reason for CME and its prognostic significance in this patient population is unknown.
Adam Ruff   +2 more
doaj   +1 more source

Modeling retinitis pigmentosa through patient-derived retinal organoids

open access: yesSTAR Protocols, 2021
Summary: Human-induced pluripotent stem cells (hiPSCs) can be differentiated into well-structured retinal organoids. In this protocol, we successfully established 3D retinae from patient-derived hiPSCs and built the retinitis pigmentosa model in vitro ...
Yan-Ping Li, Wen-Li Deng, Zi-Bing Jin
doaj   +1 more source

Advances in gene therapy technologies to treat retinitis pigmentosa [PDF]

open access: yes, 2013
Hilda Petrs-Silva, Rafael LindenInstitute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilAbstract: Retinitis pigmentosa (RP) is a class of diseases that leads to progressive degeneration of the retina.
Linden R, Petrs-Silva H
core  

Home - About - Disclaimer - Privacy